Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / People / Luke Miels
Person

Luke Miels

Tracked across 1 events · 6 articles · First seen Apr 12, 2026 · Last active Jun 10, 2026

Sentiment
0
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 0
Tech
GSK Mo-rez Cancer Drug Shows Promise
Impact: Luke Miels, GSK plc's CEO, has emphasized speeding up new medicine development, a strategy reflected in the progress of Mo-rez.
Apr 12, 2026 · 6 articles
Relationships (2)
GSK plc ↔ Luke Miels
GSK plc ↔ Luke Miels
ERGEN INTELLIGENCE
Track Luke Miels live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.